The patient is participating in another study
The patient is in an exclusion period determined by a previous study
The patient or his/her representative refuses to sign the consent
It is impossible to correctly inform the patient or his/her representative
The patient is pregnant or breastfeeding
The patient has a contraindication (or an incompatible drug association) for a treatment used in this study
The patient had a coronary stent for less than 12 months
The patient does not require treatment with aspirin or any other antiplatelet agent
The patient has a history of aspirin allergy
High bleeding risk; such as platelets <50,000 / mm3 during screening, Hb <8.5 g / dL, history of intracranial hemorrhage or subdural hematoma, major surgery, parenchymal organ biopsy or severe trauma within 30 days before inclusion, active gastrointestinal ulcer in the last 3 months;
History of Stroke in the last 3 months;
Moderate or severe liver affection associated with coagulopathy
Active infectious endocarditis
Active tumor treated at the time of inclusion associated with expected survival less than one year
